Session » Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Autoimmune Disease Transition, Disease Subsets and Prediction of Flares, Cytokines and Autoantibodies
-
Abstract Number: 1604
IFN-γ (Th1), IL4 (Th2), and IL5 (Th2) Are Elevated in Pre-Clinical SLE and Predict Transition to Classified Disease Prior to Appearance of Autoantibodies or Clinical Criteria
-
Abstract Number: 1606
Profiling a Broad Range of Autoantibodies in Healthy and Systemic Lupus Erythematosis Revealed Autoantibody Patterns Associated with Autoantibody Transition and Disease Activity
-
Abstract Number: 1607
B Cell and Neutrophil-Related Transcripts Predict and Characterize a Lupus Flare
-
Abstract Number: 1608
Erythrocyte C4d and Antibodies to Anti-C1q Are Associated with Proteinuria in Lupus Nephritis
-
Abstract Number: 1609
Dissection of the Type I Interferon Response in Systemic Lupus Erythematosus : Serum IFNα Is Elevated in Lupus Nephritis and Correlates with IFN Score; IFNβ Is Elevated in Mucocutaneous Disease
-
Abstract Number: 1610
New Autoantigens Associated with Lupus Nephritis
-
Abstract Number: 1611
Modular Transcriptional Neutrophil Signature As Predictive of Nephritis and of Its Severity in SLE Patients
-
Abstract Number: 1612
Deficient Repair of DNA Double-Strand Breaks and Increased Apoptosis in Patients with Lupus Nephritis
-
Abstract Number: 1613
Circulating microRNAs As Candidate Biomarkers of Diagnosis in Systemic Lupus Erythematosus
-
Abstract Number: 1614
Functional Analysis of Interferon Responsiveness in PBMC from SLE Donors Identifies Subgroups with Higher and Lower Disease Activity
-
Abstract Number: 1615
MiR-127-3p As a Novel Regulator of Type I Interferon Signaling Pathway in SLE
-
Abstract Number: 1616
Functional Profiling of PBMC from SLE Patients Versus Healthy Controls Identifies Subgroups with Disease-Associated Dysfunctional Signaling
-
Abstract Number: 1617
Single Cell Interferon Signatures in Lupus Patient Monocytes Reveal a Differential Impact of Interferon Signaling Between Monocyte Subtypes
-
Abstract Number: 1618
Suppression of IFN-α Production from Systemic Lupus Erythematosus Immune Complexes Via C1 Complex Enzymatic Properties
-
Abstract Number: 1619
Interferon Dysregulation in an Academic SLE Cohort Is Associated with Distinct Signaling Differences in Blood Neutrophils Versus PBMCs
-
Abstract Number: 1620
Antibody to Malondialdehyde-Acetaldehyde Adducts (MAA) As a Potential Biomarker of Inflammation in Systemic Lupus Erythrematosus (SLE)
-
Abstract Number: 1621
A Shift Towards Trans-Signalling Explains Relatively Low CRP Despite an Active Interleukin-6 (IL-6)/IL-6-Receptor (IL-6R) System in SLE
-
Abstract Number: 1622
Th1 and Th2 Cytokines Are Associated with Cerebral Atrophy in Systemic Lupus Erythematosus
-
Abstract Number: 1624
The Role of B Lymphocyte Stimulator in Monocyte Subpopulation Differentiation in SLE
-
Abstract Number: 1625
Interferon Stimulates Transglutaminase Activity on Human Monocytes and Their Microparticles
-
Abstract Number: 1626
Autoantibodies Against High Mobility Group Box 1 (HMGB1) in Patients with SLE